Qube Research & Technologies (QRT)
TSVT

Qube Research & Technologies (QRT)’s 2seventy bio TSVT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33,281
Closed -$130K – 4745
2023
Q3 		$130K Buy
+33,281
New +$218K ﹤0.01% 2570
2023
Q1 		– Sell
-50,878
Closed -$477K – 3032
2022
Q4 		$477K Buy
+50,878
New +$718K ﹤0.01% 1488
2022
Q3 		– Sell
-77,759
Closed -$1.03M – 3036
2022
Q2 		$1.03M Buy
+77,759
New +$1.06M 0.01% 1095

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s TSVT Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 33,281 shares — an estimated $130K sold.

Qube Research & Technologies (QRT) first reported a position in TSVT in Q2 2022 and held it in 3 quarters. The position peaked at $1.03M in Q2 2022. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 33,281 2seventy bio shares in Q4 2023, an estimated $130K.
  • Qube Research & Technologies (QRT) first reported a position in 2seventy bio in Q2 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s 2seventy bio position peaked at $1.03M in Q2 2022.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.